COVID-19 PRECAUTIONS:    VIEW THE practices Arizona Oncology has implemented to protect our patients and their families.
Blog     Careers     News     Bill Pay     Patient Portal     Telemedicine     

Aung Bajaj, MD Aung Bajaj, MD

Aung Bajaj, MD

Medical Oncology and Hematology

Patient Portal

Locations:

Tucson - Wilmot

Tucson - Wilmot

603 N. Wilmot Rd., #151
Tucson, AZ 85711
View Map
Call: 520-886-0206
Fax: 520-886-0829

Education & Credentials

Medical School

University of New Mexico

Residency

University of Arizona

Fellowship

University of Arizona

Board Certification

Medical Oncology and Hematology

Affiliations

  • American Medical Association
  • American Society of Clinical Oncology
  • American Society of Hematology

Languages

Burmese
English
Hindi

Biography

Dr. Bajaj finished both his residency and fellowship at the University of Arizona. He served as a co-chief fellow in his last year of fellowship, taking responsibility for junior fellows' education at the program. During this time, he also focused his training on hematology with special interest in blood and bone marrow disorders. His clinical interests include: acute and chronic leukemias, myelodysplastic syndrome, myeloproliferative neoplasms, plasma cell dyscrasias, multiple myeloma, as well as a variety of benign hematologic issues, such as bleeding and clotting disorders, anemias and immune thrombocytopenic purpura. 

Dr. Bajaj also treats patients with genitourinary tract cancers, brain tumors such as glioblastoma, head and neck cancers, and skin cancers including melanoma.

Philosophy

I believe in honest and effective communication with my patients and care providers. I realize that it takes a multidisciplinary team approach to take care of our patients with cancer. My care philosophy is that at the end of our discussion, my patients received and understood all the information given to them in regards to their diagnosis and prognosis, as well as therapeutic options available to them when deciding on a treatment. I also advocate my patients for participation in clinical trials whenever available as it allows for them to receive frontline drug therapies while contributing to research and knowledge to improve care in the future.

Arizona Oncology - The US Oncology Network